JVM-2 SMAD/TGFbeta Reporter (Luc) stable cell line
JVM-2 SMAD/TGFbeta Reporter (Luc) cells are derived from the human lymphoblast cell line JVM-2 by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. JVM-2 cell line has been widely used in cancer research and drug development. JVM-2 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
Product Specifications
No additional specifications available.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog